Reply

Affiliations

¹ Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
² Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.

Comment

Erwin Dreesen et al. Clin Gastroenterol Hepatol. 2020 Oct.

. 2020 Oct;18(11):2632-2633.

doi: 10.1016/j.cgh.2020.03.016. Epub 2020 Mar 19.

¹ Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
² Department of Gastroenterology and Hepatology, University Hospitals Leuven, Leuven, Belgium.

No abstract available

Comment on

Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease.
Dreesen E, Baert F, Laharie D, Bossuyt P, Bouhnik Y, Buisson A, Lambrecht G, Louis E, Oldenburg B, Pariente B, Pierik M, van der Woude CJ, D'Haens G, Vermeire S, Gils A. Dreesen E, et al. Clin Gastroenterol Hepatol. 2020 Mar;18(3):637-646.e11. doi: 10.1016/j.cgh.2019.05.029. Epub 2019 May 22. Clin Gastroenterol Hepatol. 2020. PMID: 31128336 Clinical Trial.
Is the Combination of Pharmacokinetic and Pharmacodynamic Monitoring of Infliximab-Treated Patients the Way Forward?
Queiroz NSF, Charabaty A. Queiroz NSF, et al. Clin Gastroenterol Hepatol. 2020 Oct;18(11):2631-2632. doi: 10.1016/j.cgh.2020.02.029. Epub 2020 Feb 21. Clin Gastroenterol Hepatol. 2020. PMID: 32092397 No abstract available.